Please login to the form below

Not currently logged in
Email:
Password:

GCI Health’s global footprint takes another step

The WPP-owned healthcare communications agency has opened its first London office
Rikki Jones

WPP-owned healthcare communications agency GCI Health has advanced its global ambitions with the launch of a London office.

The London business will focus on further building GCI Health's client base across four primary service areas: life sciences, consumer health, market access communications and strategic consulting.

Launched to cope with a growing European client base, the new business will be headed up by Rikki Jones (pictured), previously director at fellow WPP agency Cohn & Wolfe, and associate director Louise Veale, who has also moved from within the WPP network.

“We couldn't be more thrilled with the market's response to date and are looking forward to continued London-based success, in partnership with the rest of GCI Health's global management team,” said Jones.

Formally opened on October 15, 2013, the business is already up and running, describing itself as 'a trusted partner to six client companies at the global, European and UK levels in the areas of oncology, virology, auto-immune disease, diabetes and respiratory diseases'.

WPP's only speciality healthcare communications agency, GCI Health employs more than 140 people, across the US, Canada and Europe. To date, the company has worked with European clients from its US headquarters, but says that the time is now right to establish a European base.

“We had been successfully servicing global business, but as the international healthcare market continues to evolve, the time was right to find European based leaders with the passion and experience to take our business expansion to the next level,” said GCI Health chief executive Wendy Lund.

17th October 2013

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

digital launch
How can virtual pharma companies de-risk new product launches?
The risks and challenges involved in taking specialty drugs, biopharmaceuticals and drug/device combinations to market...
Not waving but drowning. Reflections on data curation in the age of information overload
...
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...

Infographics